effect of silimarin on treatment of vitiligo

Evaluation the effect of silymarin plus hair follicle transplantation on patients diagnosed as refractory vitiligo

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017052925407N3

Enrollment

Registered

2017-07-16

Start date

2016-02-08

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo. ????????

Interventions

Intervention 1: control group without placebo. Intervention 2: Intervention group Silimarin,70 mg Goldaru company oral, twice a day for 3 months.

Treatment - Drugs

control group without placebo

Intervention group Silimarin,70 mg Goldaru company oral, twice a day for 3 months

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All people over 18 years old with refractory vitiligo lesions which do not progress in the last three months,Fitzpatrick skin phototypes (SPT) III to V Exclusion criteria: Pregnant and lactating women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Perifollicular repigmentation. Timepoint: before and end of the first, second and third month of the study. Method of measurement: milimeter by using Caliper.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Amir Feily

Jahrom University of Medical Sciences

edu@juma.ac.ir+98 71 5433 6085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026